Global Signaling Profiling in a Human Model of Tumorigenic Progression Indicates a Role for Alternative RNA Splicing

Joseph A Caruso1, Nicholas J Carruthers2, Bryan Thibodeau3

  • 1Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48201, USA. joseph_caruso@wayne.edu.

Insights

Altered RNA splicing patterns correlate with breast cancer progression. Targeting RNA splicing pathways may offer new therapeutic strategies for breast cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Biology

Background:

  • Protein phosphorylation controls intracellular signaling.
  • Understanding breast cancer reprogramming requires profiling signaling changes.
  • The MCF10A cell line lineage models human breast cancer development.

Purpose of the Study:

  • To investigate how human breast cells reprogram during tumorigenic progression.
  • To profile phosphorylation changes in RNA splicing proteins.
  • To correlate splicing factor phosphorylation with mRNA splicing alterations and tumorigenicity.

Main Methods:

  • Phosphoproteomic analysis of MCF10A cell line lineage.
  • Transcriptomic analysis to assess mRNA splicing.
  • Gene ontology mapping of genes with high splicing indices.

Main Results:

  • Proteins involved in RNA splicing showed altered phosphorylation during breast cancer progression.
  • mRNA splicing patterns correlated with the degree of tumorigenicity.
  • Genes with altered splicing were significantly associated with cancer-related processes like angiogenesis and cell migration.

Conclusions:

  • Aberrant RNA splicing is a hallmark of breast cancer progression.
  • Signaling pathways regulating RNA splicing are potential therapeutic targets.
  • Further development of therapeutics targeting RNA splicing is warranted for breast cancer treatment.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.2K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Chromatin Structure and RNA Splicing02:41

Chromatin Structure and RNA Splicing

3.5K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K